Concepedia

Brian C. Magliaro

BC

Statistics

Publications

10

Citations

528

H-Index

10

Active since

2007

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Johnson & Johnson (United States)

Brian C. Magliaro is an author at United States Military Academy specializing in pharmacology, drug discovery, and neuropharmacology.

Publications per year

2007–2020

10

Publications

10

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents

P.H. Hutson, Eleftheria N. Finger, Brian C. Magliaro et al. · Neuropharmacology · 2011 · 139 citations

, , +16

Mechanism based neurotoxicity of mGlu5 positive allosteric modulators – Development challenges for a promising novel antipsychotic target

Sophie Parmentier‐Batteur, Peter H. Hutson, Karsten Menzel et al. · Neuropharmacology · 2013 · 94 citations

, , +15

Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation

Brian C. Magliaro, Colin J. Saldanha · Brain Research · 2009 · 62 citations · Full text

, , +17

Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators

Sun-Ryung Lee, Shuzhen Guo, Robert H. Scannevin et al. · Neuroscience Letters · 2007 · 61 citations

, , +14

3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts

Edward J. Brnardic, Mark E. Fraley, R. M. Garbaccio et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 40 citations · Full text

, , +13

1–5 of 10